BioFlyte Successfully Validates Aerosolized Fentanyl Detection Capabilities
“BioFlyte’s mission is to protect people and critical infrastructure, while also ensuring the continuity of operations in the face of evolving biological and chemical threats,” said Todd Sickles, CEO of BioFlyte.
- “BioFlyte’s mission is to protect people and critical infrastructure, while also ensuring the continuity of operations in the face of evolving biological and chemical threats,” said Todd Sickles, CEO of BioFlyte.
- “Key decision makers in government and public safety are struggling to control the flow of fentanyl into the country.
- Our ability to quickly and accurately detect life-threatening chemical threats like fentanyl, in addition to serious biological agents sets us apart from every other solution on the market.
- In testing with Avarint, the BioTOF was exposed to both pure fentanyl and fentanyl mixed with common cutting agents such as xylazine and acetaminophen.